Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer

Acta Urologica Japonica

Volumn 47, Issue 4, 2001, Pages 247-250

  Kurokawa, Shinsuke ^a   Morita, Tatsuo ^a   Muraishi, Osamu ^a   Tokue, Akihiko ^a  

^a NONE

Author keywords

Bladder cancer; Bladder tumor antigen test; Nuclear matrix protein 22; Tumor marker; Urinary cytology

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; NUCLEAR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CYTOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; URINE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE;

EID: 0041411278     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Miyanaga N, Akaza H, Kameyama S, et al. : Significance of the BTA test in bladder cancer : a multicenter trial. Int J Urol 4: 557-560, 1997
2. Thomas EM, Lee AB, Lisa FW, et al. : Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res 52: 422-427, 1992
3. Susan KK, Joseph VB, Gregory T, et al. : Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gene Expr 6 : 189-214, 1996
4. Miyanaga N, Akaza H, Ishikawa S, et al. : Clinical evaluation of Nuclear Matrix Protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 31 : 163-168, 1997
5. Soloway MS, Briggman JV, Carpinito GA, et al. : Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156 : 363-367, 1996
6. Papanicolaou GN and Marshall VF : Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101 : 519-521, 1945
7. Heney NM, Szyfelbein WM, Daly JJ, et al. : Positive urinary cytology in patients without evident tumor. J Urol 117 : 223-224, 1977